_expert-explains-potential-long-term-impact-of-yescarta-car-t-cell-therapy-for-patients-with-lymphoma-preview-1.jpg "Expert Explains Potential Long-term Impact of Yescarta CAR-T Cell Therapy For Patients with Lymphoma from yescarta car t cell therapy Video Screenshot Preview 1")
Gallery_expert-explains-potential-long-term-impact-of-yescarta-car-t-cell-therapy-for-patients-with-lymphoma-preview-3.jpg "Expert Explains Potential Long-term Impact of Yescarta CAR-T Cell Therapy For Patients with Lymphoma from yescarta car t cell therapy Video Screenshot Preview 3")
Gallery_expert-explains-potential-long-term-impact-of-yescarta-car-t-cell-therapy-for-patients-with-lymphoma-preview-hqdefault.jpg "Expert Explains Potential Long-term Impact of Yescarta CAR-T Cell Therapy For Patients with Lymphoma from yescarta car t cell therapy Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 51 seconds
👁 View: 499 times
Play Audio:👁 View: 499 times
Description:
curetoday
curetoday
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_expert-explains-potential-long-term-impact-of-yescarta-car-t-cell-therapy-for-patients-with-lymphoma.webp "curetoday")
Expert Explains Potential Long-term Impact of Yescarta CAR-T Cell Therapy For Patients with Lymphoma
⏲ 1 minute 51 seconds 👁 499
_the-mechanism-of-action-of-car-t.webp "Kite Pharma")
_novel-cell-type-therapeutic-platforms-in-oncology-part-ii-a-cell-by-any-other-name-does-not-work-the-same.webp "Moderator:nJoel Sandler, PhD, Principal and Practice HeadnnPanelists:nDebora Barton, MD, CMO, Carisma TherapeuticsnCharles Nicolette, PhD, CEO, CoImmune Inc.nKimberly Noonan, PhD, MPH, EVP, CSO and Founder, WindMIL TherapeuticsnnPerhaps more so than any other modality to date, cancer cell therapies have captured the imaginations and wherewithal of industry, investor, and oncologist communities alike. A fundamental but often vaguely understood component of emerging cell therapy platforms is the")
⏲ 44 min 7 sec ✓ 10-Mar-2022
_car-t-cell-therapy-explained-manufacturing-process-amp-how-it-works.webp "Henrik's Lab")
_expert-explains-potential-long-term-impact-of-yescarta-car-t-cell-therapy-for-patients-with-lymphoma.jpg)
_the-mechanism-of-action-of-car-t.jpg)
_novel-cell-type-therapeutic-platforms-in-oncology-part-ii-a-cell-by-any-other-name-does-not-work-the-same.jpg)
_car-t-cell-therapy-explained-manufacturing-process-amp-how-it-works.jpg)
![[+]](/images/menu.gif){kind=small}